According to CBN News, US President, Donald Trump, received the antibody-drug, among others, when he was sick of COVID-19 last month. Early results suggest the drug may reduce COVID-19-related hospitalization or emergency room visits in patients at high risk for disease progression. The Regeneron drug is a combo of two antibodies to enhance the chances it will prove effective. The emergency authorisation allows the use of the drug to start while studies are continuing to establish safety and effectiveness. NIGERIAN TRIBUNECOVID-19: FDA approves emergency use of drug Trump received

Source: Nigerian Tribune November 22, 2020 16:41 UTC